Stay updated on Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.

Latest updates to the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page
- Check2 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov site revision (from v3.5.0 to v3.5.3).SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 is now shown, replacing Revision: v3.4.3. This metadata update does not alter any study content or page functionality.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No changes to study details or user-facing content.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating a minor template/version change and no substantive content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedUpdate is a minor version bump from v3.4.0 to v3.4.1 with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange DetectedAdded 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

Stay in the know with updates to Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.